RWB
ABBV icon

RMR Wealth Builders’s AbbVie ABBV Stock Holding History

RMR Wealth Builders’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.83M Buy
7,287
+111
+2% +$23.9K 0.11% 91
2026
Q1 		$1.56M Sell
7,176
-98
-1% -$21.7K 0.12% 92
2025
Q4 		$1.66M Sell
7,274
-347
-5% -$79K 0.13% 87
2025
Q3 		$1.76M Sell
7,621
-285
-4% -$58K 0.15% 83
2025
Q2 		$1.47M Sell
7,906
-398
-5% -$74K 0.13% 91
2025
Q1 		$1.74M Sell
8,304
-1,605
-16% -$312K 0.18% 76
2024
Q4 		$1.76M Sell
9,909
-375
-4% -$68.9K 0.18% 68
2024
Q3 		$2.03M Sell
10,284
-278
-3% -$51.9K 0.22% 59
2024
Q2 		$1.81M Sell
10,562
-1,448
-12% -$240K 0.21% 60
2024
Q1 		$2.19M Buy
12,010
+1,230
+11% +$212K 0.26% 49
2023
Q4 		$1.67M Buy
10,780
+212
+2% +$30.9K 0.23% 51
2023
Q3 		$1.58M Sell
10,568
-711
-6% -$104K 0.25% 49
2023
Q2 		$1.52M Sell
11,279
-73
-0.6% -$10.7K 0.26% 44
2023
Q1 		$1.81M Sell
11,352
-67
-0.6% -$10.2K 0.34% 37
2022
Q4 		$1.85M Buy
11,419
+292
+3% +$44.8K 0.42% 32
2022
Q3 		$1.49M Sell
11,127
-292
-3% -$41.9K 0.37% 35
2022
Q2 		$1.75M Sell
11,419
-444
-4% -$67.8K 0.44% 36
2022
Q1 		$1.92M Buy
11,863
+1,163
+11% +$169K 0.41% 39
2021
Q4 		$1.45M Buy
10,700
+413
+4% +$48.8K 0.42% 34
2021
Q3 		$1.11M Buy
10,287
+349
+4% +$39.9K 0.33% 49
2021
Q2 		$1.12M Sell
9,938
-419
-4% -$47.2K 0.37% 47
2021
Q1 		$1.12M Buy
10,357
+9,051
+693% +$968K 0.29% 52
2020
Q4 		$140K Sell
1,306
-9,556
-88% -$918K 0.07% 182
2020
Q3 		$951K Buy
10,862
+10,416
+2,335% +$981K 0.25% 67
2020
Q2 		$44K Buy
+446
New +$39.3K 0.04% 236
2019
Q4 		$67K Buy
+758
New +$62.9K 0.06% 204

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

RMR Wealth Builders's ABBV Position: Q2 2026 in Review

RMR Wealth Builders increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $23.9K and bringing the position to 7,287 shares worth $1.83M. The position accounts for 0.11% of the portfolio, ranked #91.

RMR Wealth Builders first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $2.19M in Q1 2024. 1,601 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • RMR Wealth Builders held 7,287 shares of AbbVie worth $1.83M as of Q2 2026.
  • RMR Wealth Builders bought 111 AbbVie shares in Q2 2026, an estimated $23.9K.
  • AbbVie made up 0.11% of RMR Wealth Builders's portfolio in Q2 2026, its #91 holding.
  • RMR Wealth Builders first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
  • RMR Wealth Builders's AbbVie position peaked at $2.19M in Q1 2024.
  • 1,601 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on RMR Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.